HPV 16 infection- addressing data and furture developments: cervix vs. OP
Friday, June 17, 2016
Scientific Session on Immunology and Immunotherape
•
SSim 03
•
5:45 PM
>
7:15 PM
•
HPV 16 infection- addressing data and furture developments: cervix vs. OP
•
Europa Hall
Scientific Session on Immunology and Immunotherape
•
SSim 03-01
•
Burden and Epidemiology of HPV 16 infection and related cancers in men and women
See abstract
>
S.
Silvia
De Sanjosé
•
SSim 03-02
•
Assessing HPV 16 infection risk in the general population: the value of HPV16 variants
See abstract
>
G.
Gary
Clifford
•
Ssim 03-03
•
Appropriate methods of detection and clinical utility of HPV 16 identification
See abstract
>
F.
Francesca
Carozzi
•
Ssim 03-04
•
Positioning the role and value of therapeutic anti HPV 16/18 vaccines - Preliminary results of GTL001 (PROCERVIX) in clinical trials
See abstract
>
P.
Pierre
Van Damme
•
Ssim 03-05
•
Control strategies of HPV 16 associated cancers: the respective impact of prophylactic vaccines, therapeutic vaccines and screening
>
E.
Eduardo
Franco
|